Skip to main content

Table 3 Correlation of MUC20 expression with clinicopathologic features in CRC patients

From: Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer

Clinicopathologic features

n

MUC20 expression n (%)

χ2

P

Positive

Negative

Gender

   

0.787

0.375

 Male

88

56(63.6%)

32(26.4%)

  

 Female

62

35(56.5%)

27(43.5%)

  

Age(years)

   

4.261

0.039

 <60

94

63(67.0%)

31(33.0%)

  

 > = 60

56

28(50.0%)

28(50.0%)

  

Tumor size (diameter)

  

1.189

0.276

 <5

87

56(64.4%)

31(35.6%)

  

 > = 5

63

35(55.6%)

28(44.4%)

  

Location

   

0.224

0.636

 Colon

100

62(62.0%)

38(38.0%)

  

 Rectum

50

29(58.0%)

21(42.0%)

  

Gross appearance

   

0.685

0.710

 Exophytic

60

34(56.7%)

26(43.3%)

  

 Ulcerative

87

55(63.2%)

32(36.8%)

  

 Diffusely infiltrative

3

2(66.7%)

1(33.3%)

  

Differentiation

   

0.086

0.958

 High

7

4(57.1%)

3(42.9%)

  

 Moderate

111

67(60.4%)

44(39.6%)

  

 Low

32

20(62.5%)

12(37.5%)

  

TNM stage

   

0.264

0.607

 II

80

47(58.8%)

33(41.2%)

  

 III

70

44(62.9%)

26(37.1%)

  

Recurrence

   

5.849

0.016

 Yes

47

36(76.6%)

11(33.4%)

  

 No

90

50(55.6%)

40(44.4%)

  

Status

   

5.960

0.015

 Survival

93

52(55.9%)

41(44.1%)

  

 Death

41

32(78.0%)

9(22.0%)

 Â